Navigation Links
New Treatment Eyed for Ewing's Sarcoma
Date:12/24/2009

Figitumumab fights tumors and appears to be well-tolerated, researchers say

WEDNESDAY, Dec. 23 (HealthDay News) -- Preliminary research suggests that the anticancer drug figitumumab might be an effective treatment for Ewing's sarcoma, a cancer that affects the areas in and near the bone, mainly in teenage boys.

The drug must undergo two more phases of testing, however, according to a report published in the Dec. 23 online edition of The Lancet Oncology.

In the first phase of research, scientists looked at 29 patients with advanced sarcomas who received the drug between 2006 and 2008. The researchers wanted to assess its safety and ability to be tolerated.

Patients did experience some side effects, such as deep venous thrombosis, back pain and vomiting. Some of the patients appeared to respond well to the drug, the study authors noted.

"Figitumumab is well-tolerated and has antitumor activity in Ewing's sarcoma, warranting further investigation in this disease," the researchers wrote. "Our results show that figitumumab can be safe for both adult and pediatric sarcoma patients, and has single-agent antitumor activity in different sarcoma subtypes, including Ewing's sarcoma."

In a commentary accompanying the study, doctors wrote that "five-drug chemotherapy is routine in the treatment of Ewing's sarcoma, therefore improvement in outcome for these patients will likely require demonstration of the feasibility of combining the antibody with standard chemotherapy."

More information

The U.S. National Library of Medicine has more on Ewing's sarcoma.



-- Randy Dotinga



SOURCE: The Lancet Oncology, news release, Dec. 23, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Modernizing the treatment of sexual dysfunction in men
2. Autism Treatment Crisis: Insufficient Number of Providers to Meet Alarming Increase in Need
3. New insights into mushroom-derived drug promising for cancer treatment
4. Protein link may be key to new treatment for aggressive brain tumor
5. Michael J. Fox Foundation Awards $1 Million for Critical Step Toward Development of Dyskinesia Treatments
6. Diabetes Insight Could Lead to Better Treatments
7. IBS Treatment Center Calls on McCain to Support IBS Research
8. Targeting brain cancer cell metabolism may provide new treatment
9. Urinary Incontinence Rates Increase Worldwide As Awareness Grows About Treatment Options: Urethral Slings Are Popular Alternatives When Medications Fail
10. Free Webinar Series at Aqualipo.com Shows How New Combination Liposuction/Fat Transfer Treatment Helps Patients Slim Down and Reduce Facial Wrinkling
11. Early Treatment of Hearing, Vision Helps in Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... Ultimate ... K-20 Education Summit to be held March 23-25, 2017 in Tampa, and reminded ... 2017. , The keynote speakers include Dr. Michelle R. Weise, executive director of ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... Sharon Kleyne, ... the air to educate listeners about the benefits of making new water infrastructure a ... Kleyne said, “it’s appropriate that we expect water infrastructure to become a top priority ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... today it has earned organic certification under the USDA National Organic Program (NOP) ... Organic Certification process, we have established organic production and handling systems to complement ...
(Date:1/23/2017)... ... ... at the Mill”: a story of love and redemption, hope and uncertainty as a ... , “The Inn at the Mill” is the creation of published author, Lois Kulp, ... now living in Berks County on Crow Hill. The inn, the mill and ...
(Date:1/23/2017)... Atlanta, Georgia (PRWEB) , ... January 23, 2017 , ... Valentine’s Day is a time ... to their loved ones. For those who may be looking for the ideal present, Atlanta-based ... gift certificate and get an additional $25 free. Or, spend $200 and get $50 free. ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 20, 2017 ResMed (NYSE: RMD ), BMC ... Winter Haven, Florida ) today announced they have agreed on ... 3B will be permitted to sell their existing products in exchange ... settlement payment to 3B to close the Florida ... an admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017  Today, during ... Conference, "PI3K Pathways in Immunology, Growth Disorders ... (NASDAQ: INFI ) presented preclinical ... candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical ... help overcome resistance to checkpoint inhibition by ...
(Date:1/20/2017)... -- Research and Markets has announced the addition ... BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver ... - 2024" report to their offering. ... The global clinical laboratory testing market ... Introduction of innovative solutions on the grounds of maximum efficiency and ...
Breaking Medicine Technology: